Apogee Therapeutics, Inc. APGE
CIK 0001974640
Form 4 transactions dated Sep 1, 2023 to Sep 26, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $990.77K
- Sold
- $187.54M
Sep 1, 2023 – Sep 3, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2024-12-12 | McKenna Mark C. Director | Purchase | $990.77K 20,000 shares bought | New holding Direct holding | ▾ |
| 2024-12-11 | Dambkowski Carl Chief Medical Officer | Sale10b5-1 footnote | $221.36K 4,540 shares sold | 1.73% sold Direct holding | ▾ |
| 2024-12-04 | Dambkowski Carl Chief Medical Officer | Sale10b5-1 footnote | $307.06K 6,665 shares sold | 2.49% sold Direct holding | ▾ |
| 2024-12-04 | HENDERSON MICHAEL THOMAS Chief Executive Officer · Director | Sale10b5-1 footnote | $698.65K 15,000 shares sold | 1.12% sold Direct holding | ▾ |
| 2024-11-06 | Dambkowski Carl Chief Medical Officer | Sale10b5-1 footnote | $394.04K 6,665 shares sold | 2.43% sold Direct holding | ▾ |
| 2024-11-06 | HENDERSON MICHAEL THOMAS Chief Executive Officer · Director | Sale10b5-1 footnote | $888.32K 15,000 shares sold | 1.11% sold Direct holding | ▾ |
| 2024-10-02 | Dambkowski Carl Chief Medical Officer | Sale10b5-1 footnote | $374.95K 6,665 shares sold | 2.37% sold Direct holding | ▾ |
| 2024-10-02 | HENDERSON MICHAEL THOMAS Chief Executive Officer · Director | Sale10b5-1 footnote | $2.25M 40,000 shares sold | 2.87% sold Direct holding | ▾ |
| 2024-09-04 | Dambkowski Carl Chief Medical Officer | Sale10b5-1 footnote | $316.97K 6,665 shares sold | 2.32% sold Direct holding | ▾ |
| 2024-09-04 | HENDERSON MICHAEL THOMAS Chief Executive Officer · Director | Sale10b5-1 footnote | $1.90M 40,000 shares sold | 2.79% sold Direct holding | ▾ |
Showing 15 / 15 record groups in 2024. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 15 of 15 purchase / sale groups and 21 of 21 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"APGE","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.